NMR-based analysis of protein-ligand interactions

Analytical and Bioanalytical Chemistry

Volumn 406, Issue 4, 2014, Pages 943-956

  Cala, Olivier ^a,b,c   Guillière, Florence ^a,b,c   Krimm, Isabelle ^a,b,c  

^a UNIVERSITÉ DE LYON   (France)

^b UNIVERSITÉ LYON 1   (France)

^c Institut des Sciences Analytiques   (France)

Author keywords

NMR screening; Protein ligand interactions; Saturation transfer difference; Transferred nuclear Overhauser effect; Water ligand observed via gradient spectroscopy

Indexed keywords

CELL SURFACE RECEPTOR; LIGAND;

ANIMAL; CHEMISTRY; EVALUATION STUDY; METABOLISM; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROTEIN BINDING; REVIEW;

ANIMALS; LIGANDS; MAGNETIC RESONANCE SPECTROSCOPY; PROTEIN BINDING; RECEPTORS, CELL SURFACE;

EID: 84894899532     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-013-6931-0     Document Type: Review

References (86)

1. Keiser MJ, Irwin JJ, Shoichet BK (2010) The chemical basis of pharmacology. Biochemistry 49:10267-10276
2. Wells JA, McClendon CL (2007) Reaching for high-hanging fruit in drug discovery at protein-protein interfaces. Nature 450:1001-1009
3. Metz JT, Hajduk PJ (2010) Rational approaches to targeted polypharmacology: creating and navigating protein-ligand interaction networks. Curr Opin Chem Biol 14:498-504
4. Arkin MR, Wells JA (2004) Small-molecule inhibitors of protein-protein interactions: progressing towards the dream. Nat Rev Drug Discov 3:301-317
5. Morelli X, Bourgeas R, Roche P (2011) Chemical and structural lessons from recent successes in protein-protein interaction inhibition (2P2I). Curr Opin Chem Biol 15:475-481
6. Renaud J-P, Delsuc M-A (2009) Biophysical techniques for ligand screening and drug design. Curr Opin Pharmacol 9:622-628
7. Niesen FH, Berglund H, Vedadi M (2007) The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability. Nat Protoc 2:2212-2221
8. Luk KC, Hyde EG, Trojanowski JQ, Lee VM-Y (2007) Sensitive fluorescence polarization technique for rapid screening of α-synuclein oligomerization/fibrillization inhibitors. Biochemistry 46:12522-12529
9. Jonker N, Kool J, Irth H, Niessen WA (2011) Recent developments in protein-ligand affinity mass spectrometry. Anal Bioanal Chem 399:2669-2681
10. Trott O, Olson AJ (2010) AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31:455-461
11. Huang S-Y, Grinter SZ, Zou X (2010) Scoring functions and their evaluation methods for protein-ligand docking: recent advances and future directions. Phys Chem Chem Phys 12:12899-12908
12. Joachimiak A (2009) High-throughput crystallography for structural genomics. Curr Opin Struct Biol 19:573-584
13. Kay LE (2011) NMR studies of protein structure and dynamics - a look backwards and forwards. J Magn Reson 213:492-494
14. Pellecchia M, Bertini I, Cowburn D, Dalvit C, Giralt E, Jahnke W, James TL, Homans SW, Kessler H, Luchinat C, Meyer B, Oschkinat H, Peng J, Schwalbe H, Siegal G (2008) Perspectives on NMR in drug discovery: a technique comes of age. Nat Rev Drug Discov 7:738-745
15. Peng JW, Moore J, Abdul-Manan N (2004) NMR experiments for lead generation in drug discovery. Prog Nucl Magn Reson Spectrosc 44:225-256
16. Goldflam M, Tarragó T, Gairí M, Giralt E (2012) NMR studies of protein-ligand interactions. In: Shekhtman A, Burz DS (eds) Protein NMR techniques. Humana, Totowa, pp 233-259
17. Billeter M, Wagner G, Wüthrich K (2008) Solution NMR structure determination of proteins revisited. J Biomol NMR 42:155-158
18. Cavanagh J, Fairbrother WJ, Palmer AG, Rance M, Skelton NJ (2007) Protein NMR spectroscopy. Academic, New York
19. Meyer B, Peters T (2003) NMR spectroscopy techniques for screening and identifying ligand binding to protein receptors. Angew Chem Int Ed 42:864-890
20. Erlanson D (2012) Introduction to fragment-based drug discovery. In: Davies TG, Hyvönen M (eds) Fragment-based drug discovery and X-ray crystallography. Springer, Berlin, pp 1-32
21. Murray CW, Rees DC (2009) The rise of fragment-based drug discovery. Nat Chem 1:187-192
22. Post CB (2003) Exchange-transferred NOE spectroscopy and bound ligand structure determination. Curr Opin Struct Biol 13:581-588
23. Li D, DeRose E, London R (1999) The inter-ligand Overhauser effect: a powerful new NMR approach for mapping structural relationships of macromolecular ligands. J Biomol NMR 15:71-76
24. Li D, London R (2002) Ligand discovery using the inter-ligand Overhauser effect: horse liver alcohol dehydrogenase. Biotechnol Lett 24:623-629
25. Li D, Levy LA, Gabel SA, Lebetkin MS, DeRose EF, Wall MJ, Howell EE, London RE (2001) Interligand Overhauser effects in type II dihydrofolate reductase. Biochemistry 40:4242-4252
26. Becattini B, Pellecchia M (2006) SAR by ILOEs: an NMR-based approach to reverse chemical genetics. Chem Eur J 12:2658-2662
27. Rega MF, Wu B, Wei J, Zhang Z, Cellitti JF, Pellecchia M (2011) SAR by interligand nuclear Overhauser effects (ILOEs) based discovery of acylsulfonamide compounds active against Bcl-xL and Mcl-1. J Med Chem 54:6000-6013
28. Rademacher C, Guiard J, Kitov PI, Fiege B, Dalton KP, Parra F, Bundle DR, Peters T (2011) Targeting norovirus infection - multivalent entry inhibitor design based on NMR experiments. Chem Eur J 17:7442-7453
29. Orts J, Griesinger C, Carlomagno T (2009) The INPHARMA technique for pharmacophore mapping: a theoretical guide to the method. J Magn Reson 200:64-73
30. Sánchez-Pedregal VM, Reese M, Meiler J, Blommers MJJ, Griesinger C, Carlomagno T (2005) The INPHARMA method: protein-mediated interligand NOEs for pharmacophore mapping. Angew Chem Int Ed 44:4172-4175
31. Krimm I (2012) INPHARMA-based identification of ligand binding site in fragment-based drug design. Med Chem Commun 3:605-610
32. Becattini B, Sareth S, Zhai D, Crowell KJ, Leone M, Reed JC, Pellecchia M (2004) Targeting apoptosis via chemical design: inhibition of Bid-induced cell death by small organic molecules. Chem Biol 11:1107-1117
33. Chen J, Zhang Z, Stebbins JL, Zhang X, Hoffman R, Moore A, Pellecchia M (2007) A fragment-based approach for the discovery of isoform-specific p38α inhibitors. ACS Chem Biol 2:329-336
34. Fejzo J, Lepre CA, Peng JW, Bemis GW, Ajay MMA, Moore JM (1999) The SHAPES strategy: an NMR-based approach for lead generation in drug discovery. Chem Biol 6:755-769
35. Becattini B, Culmsee C, Leone M, Zhai D, Zhang X, Crowell KJ, Rega MF, Landshamer S, Reed JC, Plesnila N, Pellecchia M (2006) Structure-activity relationships by interligand NOE-based design and synthesis of antiapoptotic compounds targeting Bid. Proc Natl Acad Sci USA 103:12602-12606
36. Sledz P, Silvestre HL, Hung AW, Ciulli A, Blundell TL, Abell C (2010) Optimization of the interligand Overhauser effect for fragment linking: application to inhibitor discovery against Mycobacterium tuberculosis pantothenate synthetase. J Am Chem Soc 132:4544-4545
37. Begley DW, Zheng S, Varani G (2010) Fragment-based discovery of novel thymidylate synthase leads by NMR screening and group epitope mapping. Chem Biol Drug Des 76:218-233
38. Moseley HNB, Curto EV, Krishna NR (1995) Complete relaxation and conformational exchange matrix (CORCEMA) analysis of NOESY spectra of interacting systems; two-dimensional transferred NOESY. Academic, Orlando
39. Orts J, Tuma J, Reese M, Grimm SK, Monecke P, Bartoschek S, Schiffer A, Wendt KU, Griesinger C, Carlomagno T (2008) Crystallography-independent determination of ligand binding modes. Angew Chem Int Ed 47:7736-7740
40. Reese M, Sánchez-Pedregal VM, Kubicek K, Meiler J, Blommers MJJ, Griesinger C, Carlomagno T (2007) Structural basis of the activity of the microtubule-stabilizing agent epothilone A studied by NMR spectroscopy in solution. Angew Chem Int Ed 46:1864-1868
41. Bartoschek S, Klabunde T, Defossa E, Dietrich V, Stengelin S, Griesinger C, Carlomagno T, Focken I, Wendt KU (2010) Drug design for G-protein-coupled receptors by a ligand-based NMR method. Angew Chem Int Ed 49:1426-1429
42. Mayer M, Meyer B (1999) Characterization of ligand binding by saturation transfer difference NMR spectroscopy. Angew Chem Int Ed 38:1784-1788
43. Bretonnet A-S, Jochum A, Walker O, Krimm I, Goekjian P, Marcillat O, Lancelin J-M (2007) NMR screening applied to the fragment-based generation of inhibitors of creatine kinase exploiting a new interaction proximate to the ATP binding site. J Med Chem 50:1865-1875
44. Bhunia A, Bhattacharjya S, Chatterjee S (2012) Applications of saturation transfer difference NMR in biological systems. Drug Discov Today 17:505-513
45. Angulo J, Nieto P (2011) STD-NMR: application to transient interactions between biomolecules - a quantitative approach. Eur Biophys J 40:1357-1369
46. Wagstaff JL, Taylor SL, Howard MJ (2013) Recent developments and applications of saturation transfer difference nuclear magnetic resonance (STD NMR) spectroscopy. Mol Biosyst 9:571-577
47. Vogtherr M, Peters T (2000) Application of NMR based binding assays to identify key hydroxy groups for intermolecular recognition. J Am Chem Soc 122:6093-6099
48. Räuber C, Berger S (2010) 13C-NMR detection of STD spectra. Magn Reson Chem 48:91-93
49. Nagaraja CS (2006) Heteronuclear saturation transfer difference (HSTD) experiment for detection of ligand binding to proteins. Chem Phys Lett 420:340-346
50. Xia Y, Zhu Q, Jun K-Y, Wang J, Gao X (2010) Clean STD-NMR spectrum for improved detection of ligand-protein interactions at low concentration of protein. Magn Reson Chem 48:918-924
51. Furihata K, Shimotakahara S, Shibusawa Y, Tashiro M (2009) Application of WET sequence for the detection of the ligand signals resonating close to water. Magn Reson Chem 47:971-976
52. Furithata K, Shimotakahara S, Shibusawa Y, Tashiro M (2010) An effective pulse sequence for detecting a ligand binding with a protein receptor using a WET sequence and the repeated Z-filters. Anal Sci 26:1107-1110
53. Campos-Olivas R (2011) NMR screening and hit validation in fragment based drug discovery. Curr Top Med Chem 11:43-67
54. Benie AJ, Moser R, Bäuml E, Blaas D, Peters T (2002) Virus - ligand interactions: identification and characterization of ligand binding by NMR spectroscopy. J Am Chem Soc 125:14-15
55. Rademacher C, Krishna NR, Palcic M, Parra F, Peters T (2008) NMR experiments reveal the molecular basis of receptor recognition by a calicivirus. J Am Chem Soc 130:3669-3675
56. Meinecke R, Meyer B (2001) Determination of the binding specificity of an integral membrane protein by saturation transfer difference NMR: RGD peptide ligands binding to Integrin αIIbβ3. J Med Chem 44:3059-3065
57. Claasen B, Axmann M, Meinecke R, Meyer B (2004) Direct observation of ligand binding to membrane proteins in living cells by a saturation transfer double difference (STDD) NMR spectroscopy method shows a significantly higher affinity of integrin αIIbβ3 in native platelets than in liposomes. J Am Chem Soc 127:916-919
58. Mari S, Serrano-Gómez D, Cañada FJ, Corbí AL, Jiménez-Barbero J (2005) 1D saturation transfer difference NMR experiments on living cells: the DC-SIGN/oligomannose interaction. Angew Chem Int Ed 44:296-298
59. Pereira A, Pfeifer TA, Grigliatti TA, Andersen RJ (2009) Functional cell-based screening and saturation transfer double-difference NMR have identified haplosamate A as a cannabinoid receptor agonist. ACS Chem Biol 4:139-144
60. Wang Y-S, Liu D, Wyss DF (2004) Competition STD NMR for the detection of high-affinity ligands and NMR-based screening. Magn Reson Chem 42:485-489
61. McCoy MA, Senior MM, Wyss DF (2005) Screening of protein kinases by ATP-STD NMR spectroscopy. J Am Chem Soc 127:7978-7979
62. Krimm I, Lancelin J-M, Praly J-P (2012) Binding evaluation of fragment-based scaffolds for probing allosteric enzymes. J Med Chem 55:1287-1295
63. Mayer M, Meyer B (2001) Group epitope mapping by saturation transfer difference NMR to identify segments of a ligand in direct contact with a protein receptor. J Am Chem Soc 123:6108-6117
64. Angulo J, Langpap B, Blume A, Biet T, Meyer B, Krishna NR, Peters H, Palcic MM, Peters T (2006) Blood group B galactosyltransferase: insights into substrate binding from NMR experiments. J Am Chem Soc 128:13529-13538
65. Szczepina MG, Zheng RB, Completo GC, Lowary TL, Pinto BM (2009) STD-NMR studies suggest that two acceptor substrates for GlfT2, a bifunctional galactofuranosyltransferase required for the biosynthesis of Mycobacterium tuberculosis arabinogalactan, compete for the same binding site. ChemBioChem 10:2052-2059
66. Ji Z, Yao Z, Liu M (2009) Saturation transfer difference nuclear magnetic resonance study on the specific binding of ligand to protein. Analy Biochem 385:380-382
67. Angulo J, Enríquez-Navas PM, Nieto PM (2010) Ligand-receptor binding affinities from saturation transfer difference (STD) NMR spectroscopy: the binding isotherm of STD initial growth rates. Chem Eur J 16:7803-7812
68. Mayer M, James TL (2004) NMR-based characterization of phenothiazines as a RNA binding scaffold. J Am Chem Soc 126:4453-4460
69. Kemper S, Patel MK, Errey JC, Davis BG, Jones JA, Claridge TDW (2010) Group epitope mapping considering relaxation of the ligand (GEM-CRL): including longitudinal relaxation rates in the analysis of saturation transfer difference (STD) experiments. J Magn Reson 203:1-10
70. Jayalakshmi V, Krishna NR (2002) Complete relaxation and conformational exchange matrix (CORCEMA) analysis of intermolecular saturation transfer effects in reversibly forming ligand-receptor complexes. J Magn Reson 155:106-118
71. Jayalakshmi V, Rama Krishna N (2004) CORCEMA refinement of the bound ligand conformation within the protein binding pocket in reversibly forming weak complexes using STD-NMR intensities. J Magn Reson 168:36-45
72. Jayalakshmi V, Biet T, Peters T, Krishna NR (2004) Refinement of the conformation of UDP - galactose bound to galactosyltransferase using the STD NMR intensity-restrained CORCEMA optimization. J Am Chem Soc 126:8610-8611
73. Enríquez-Navas PM, Marradi M, Padro D, Angulo J, Penadés S (2011) A solution NMR study of the interactions of oligomannosides and the anti-HIV-1 2G12 antibody reveals distinct binding modes for branched ligands. Chem Eur J 17:1547-1560
74. Angulo J, Díaz I, Reina JJ, Tabarani G, Fieschi F, Rojo J, Nieto PM (2008) Saturation transfer difference (STD) NMR spectroscopy characterization of dual binding mode of a mannose disaccharide to DC-SIGN. ChemBioChem 9:2225-2227
75. Dalvit C, Cottens S, Ramage P, Hommel U (1999) Half-filter experiments for assignment, structure determination and hydration analysis of unlabelled ligands bound to 13C/15 N labelled proteins. J Biomol NMR 13:43-50
76. Dalvit C, Fogliatto G, Stewart A, Veronesi M, Stockman B (2001) WaterLOGSY as a method for primary NMR screening: practical aspects and range of applicability. J Biomol NMR 21:349-359
77. Dalvit C, Pevarello P, Tatò M, Veronesi M, Vulpetti A, Sundström M (2000) Identification of compounds with binding affinity to proteins via magnetization transfer from bulk water. J Biomol NMR 18:65-68
78. Barelier S, Pons J, Gehring K, Lancelin J-M, Krimm I (2010) Ligand specificity in fragment-based drug design. J Med Chem 53:5256-5266
79. Dalvit C, Fasolini M, Flocco M, Knapp S, Pevarello P, Veronesi M (2002) NMR-based screening with competition water - ligand observed via gradient spectroscopy experiments: detection of high-affinity ligands. J Med Chem 45:2610-2614
80. Ludwig C, Michiels PJA, Lodi A, Ride J, Bunce C, Günther UL (2008) Evaluation of solvent accessibility epitopes for different dehydrogenase inhibitors. ChemMedChem 3:1371-1376
81. Gossert A, Henry C, Blommers MJ, Jahnke W, Fernández C (2009) Time efficient detection of protein-ligand interactions with the polarization optimized PO-WaterLOGSY NMR experiment. J Biomol NMR 43:211-217
82. Hu J, Eriksson P-O, Kern G (2010) Aroma WaterLOGSY: a fast and sensitive screening tool for drug discovery. Magn Reson Chem 48:909-911
83. Karle M, Knecht W, Xue Y (2012) Discovery of benzothiazole guanidines as novel inhibitors of thrombin and trypsin IV. Bioorg Med Chem Lett 22:4839-4843
84. Ludwig C, Michiels PJA, Wu X, Kavanagh KL, Pilka E, Jansson A, Oppermann U, Günther UL (2007) SALMON: solvent accessibility, ligand binding, and mapping of ligand orientation by NMR spectroscopy. J Med Chem 51:1-3
85. Szczepina MG, Bleile DW, Müllegger J, Lewis AR, Pinto BM (2011) WaterLOGSY NMR experiments in conjunction with molecular-dynamics simulations identify immobilized water molecules that bridge peptide mimic MDWNMHAA to anticarbohydrate antibody SYA/J6. Chem Eur J 17:11438-11445
86. Potenza D, Vasile F, Belvisi L, Civera M, Araldi EMV (2011) STD and trNOESY NMR study of receptor-ligand interactions in living cancer cells. ChemBioChem 12:695-699